Cytokinetics, Incorporated
CYTK
Cena:
$ 76.94
-1.12 (-1.43%)
Valuace
85
Růst
15
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK INC. | 14.7 mil | 14.40% | 0.00% | 0.02% | 2013-09-30 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 17.5 mil | 14.36% | 0.08% | 0.80% | 2022-12-31 |
| BLACKROCK, INC. | 16.5 mil | 13.56% | 0.00% | 0.02% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 15.5 mil | 13.14% | 0.00% | 0.01% | 2024-09-30 |
| VANGUARD GROUP INC | 12.0 mil | 10.04% | 0.00% | 0.01% | 2013-09-30 |
| FMR LLC | 10.7 mil | 8.79% | 0.00% | 0.04% | 2013-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.0 mil | 6.56% | 0.01% | 0.10% | 2020-06-30 |
| TUDOR INVESTMENT CORP ET AL | 6.0 mil | 5.02% | 0.01% | 0.01% | 2025-09-30 |
| STATE STREET CORP | 5.7 mil | 4.71% | 0.00% | 0.01% | 2013-06-30 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 4.6 mil | 4.49% | 28.63% | 28.63% | 2023-12-31 |
| AVORO CAPITAL ADVISORS LLC | 3.3 mil | 2.73% | 2.16% | 2.16% | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.2 mil | 2.64% | 0.00% | 0.01% | 2013-06-30 |
| BANK OF AMERICA CORP /DE/ | 3.1 mil | 2.56% | 0.00% | 0.02% | 2013-09-30 |
| RTW INVESTMENTS, LP | 2.7 mil | 2.23% | 0.05% | 1.78% | 2020-09-30 |
| GOLDMAN SACHS GROUP INC | 2.2 mil | 1.81% | 0.00% | 0.02% | 2013-09-30 |
| BOXER CAPITAL, LLC | 2.1 mil | 1.78% | -0.55% | 5.44% | 2020-12-31 |
| UBS GROUP AG | 2.1 mil | 1.70% | 0.01% | 0.02% | 2014-12-31 |
| LORD, ABBETT & CO. LLC | 1.6 mil | 1.67% | 0.42% | 0.48% | 2021-12-31 |
| PFM HEALTH SCIENCES, LP | 1.8 mil | 1.49% | 0.55% | 5.26% | 2020-12-31 |
| POLAR CAPITAL HOLDINGS PLC | 1.7 mil | 1.36% | -0.21% | 0.39% | 2020-12-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.6 mil | 1.30% | 0.00% | 0.01% | 2020-09-30 |
| MORGAN STANLEY | 1.5 mil | 1.23% | 0.00% | 0.01% | 2013-09-30 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.5 mil | 1.21% | 1.99% | 1.99% | 2026-03-31 |
| NORTHERN TRUST CORP | 1.4 mil | 1.18% | 0.00% | 0.01% | 2013-09-30 |
| ALLIANCEBERNSTEIN L.P. | 1.4 mil | 1.16% | -0.01% | 0.01% | 2013-09-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4 mil | 1.14% | 0.00% | 0.01% | 2013-09-30 |
| FARALLON CAPITAL MANAGEMENT LLC | 1.1 mil | 1.13% | 0.45% | 0.45% | 2020-03-31 |
| DEEP TRACK CAPITAL, LP | 1.4 mil | 1.13% | -2.30% | 1.48% | 2023-12-31 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.3 mil | 1.11% | -0.01% | 0.26% | 2024-03-31 |
| CAPITAL INTERNATIONAL INVESTORS | 1.3 mil | 1.10% | 0.01% | 0.02% | 2024-12-31 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 1.3 mil | 1.06% | 0.17% | 0.86% | 2021-09-30 |
| TOMS CAPITAL INVESTMENT MANAGEMENT LP | 0.00 mld | 1.04% | 3.45% | 3.45% | 2023-12-31 |
| CAPTION MANAGEMENT, LLC | 1.2 mil | 1.01% | 0.26% | 0.47% | 2023-09-30 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.2 mil | 0.95% | 0.37% | 1.97% | 2025-06-30 |
| ORBIMED ADVISORS LLC | 1.1 mil | 0.90% | -0.56% | 0.89% | 2024-03-31 |
| CITADEL ADVISORS LLC | 1.1 mil | 0.90% | 0.00% | 0.01% | 2014-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 1.1 mil | 0.90% | 0.01% | 0.04% | 2017-06-30 |
| JANUS HENDERSON GROUP PLC | 1.1 mil | 0.89% | 0.00% | 0.03% | 2021-09-30 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.1 mil | 0.89% | 0.24% | 0.24% | 2026-03-31 |
| HAP TRADING, LLC | 862.30 tis | 0.85% | 0.90% | 0.90% | 2023-09-30 |
| RP MANAGEMENT, LLC | 980.39 tis | 0.83% | 5.65% | 28.38% | 2024-06-30 |
| BANK OF NEW YORK MELLON CORP | 1.0 mil | 0.82% | 0.00% | 0.01% | 2013-09-30 |
| WOODLINE PARTNERS LP | 1.0 mil | 0.82% | -0.16% | 0.25% | 2023-12-31 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.00 mld | 0.82% | 1.57% | 3.15% | 2025-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 992.55 tis | 0.81% | 0.08% | 0.08% | 2026-03-31 |
| 980.39 tis | 0.80% | 1.04% | 37.40% | 2025-12-31 | |
| PENTWATER CAPITAL MANAGEMENT LP | 920.90 tis | 0.78% | -0.02% | 0.48% | 2024-03-31 |
| JPMORGAN CHASE & CO | 903.81 tis | 0.74% | 0.00% | 0.00% | 2017-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 898.95 tis | 0.74% | 0.00% | 0.01% | 2018-06-30 |
| ANTARA CAPITAL LP | 700.00 tis | 0.73% | 3.94% | 3.94% | 2023-12-31 |
| LOGOS GLOBAL MANAGEMENT LP | 875.00 tis | 0.72% | 1.73% | 2.88% | 2025-12-31 |
| JANE STREET GROUP, LLC | 840.50 tis | 0.70% | 0.00% | 0.01% | 2024-09-30 |
| BNP PARIBAS ARBITRAGE, SNC | 854.37 tis | 0.70% | 0.01% | 0.03% | 2013-12-31 |
| GTS SECURITIES LLC | 670.90 tis | 0.70% | 0.09% | 0.10% | 2023-09-30 |
| MELQART ASSET MANAGEMENT (UK) LTD | 843.95 tis | 0.69% | 1.59% | 5.48% | 2024-03-31 |
| NORGES BANK | 807.07 tis | 0.67% | 0.01% | 0.01% | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 799.62 tis | 0.66% | 0.01% | 0.01% | 2026-03-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 779.45 tis | 0.64% | 0.02% | 0.06% | 2023-03-31 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 771.00 tis | 0.63% | 0.01% | 0.01% | 2026-03-31 |
| FISHER ASSET MANAGEMENT, LLC | 768.26 tis | 0.63% | 0.00% | 0.02% | 2023-12-31 |
| IKARIAN CAPITAL, LLC | 603.50 tis | 0.63% | 4.00% | 4.72% | 2023-09-30 |
| ARMISTICE CAPITAL, LLC | 764.54 tis | 0.63% | 0.15% | 0.90% | 2024-03-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 750.95 tis | 0.62% | 0.01% | 0.05% | 2023-09-30 |
| BROWN ADVISORY INC | 731.15 tis | 0.61% | 0.00% | 0.06% | 2024-03-31 |
| VESTAL POINT CAPITAL, LP | 725.00 tis | 0.61% | -3.38% | 1.80% | 2023-12-31 |
| AVIDITY PARTNERS MANAGEMENT LP | 600.00 tis | 0.59% | 1.36% | 1.36% | 2024-03-31 |
| DEUTSCHE BANK AG\ | 565.15 tis | 0.59% | 0.02% | 0.02% | 2013-09-30 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 714.34 tis | 0.59% | -0.01% | 0.05% | 2020-12-31 |
| D. E. SHAW & CO., INC. | 706.63 tis | 0.58% | 0.02% | 0.03% | 2024-03-31 |
| ASSENAGON ASSET MANAGEMENT S.A. | 554.66 tis | 0.58% | 0.12% | 0.12% | 2023-03-31 |
| AFFINITY ASSET ADVISORS, LLC | 700.48 tis | 0.57% | -0.51% | 2.38% | 2025-09-30 |
| FEDERATED HERMES, INC. | 699.45 tis | 0.57% | 0.02% | 0.08% | 2024-03-31 |
| JENNISON ASSOCIATES LLC | 673.93 tis | 0.57% | 0.02% | 0.02% | 2025-03-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 555.11 tis | 0.54% | -0.08% | 0.11% | 2024-03-31 |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 660.31 tis | 0.54% | -0.53% | 3.69% | 2024-12-31 |
| MARSHALL WACE, LLP | 656.61 tis | 0.54% | 0.02% | 0.04% | 2020-09-30 |
| COWEN AND COMPANY, LLC | 510.00 tis | 0.51% | 0.51% | 0.51% | 2024-03-31 |
| SARISSA CAPITAL MANAGEMENT LP | 588.36 tis | 0.49% | 5.33% | 17.93% | 2024-03-31 |
| ARTAL GROUP S.A. | 494.42 tis | 0.49% | -0.22% | 0.68% | 2020-12-31 |
| GREAT POINT PARTNERS LLC | 474.20 tis | 0.47% | 2.71% | 4.92% | 2023-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 470.97 tis | 0.46% | 0.00% | 0.04% | 2023-12-31 |
| AMERIPRISE FINANCIAL INC | 545.81 tis | 0.45% | 0.00% | 0.01% | 2017-06-30 |
| FRANKLIN RESOURCES INC | 537.62 tis | 0.45% | 0.00% | 0.01% | 2021-09-30 |
| TD ASSET MANAGEMENT INC | 544.01 tis | 0.45% | 0.00% | 0.03% | 2021-12-31 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 540.17 tis | 0.45% | -0.16% | 2.52% | 2023-12-31 |
| NOMURA HOLDINGS INC | 520.50 tis | 0.44% | 0.02% | 0.03% | 2023-12-31 |
| AQR CAPITAL MANAGEMENT LLC | 513.29 tis | 0.43% | 0.01% | 0.02% | 2019-09-30 |
| INVESCO LTD. | 501.88 tis | 0.42% | 0.00% | 0.00% | 2015-06-30 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 496.67 tis | 0.42% | 0.00% | 0.01% | 2024-06-30 |
| BARCLAYS PLC | 492.81 tis | 0.41% | 0.00% | 0.00% | 2013-09-30 |
| ABRDN PLC | 483.06 tis | 0.40% | -0.03% | 0.05% | 2023-12-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 479.61 tis | 0.40% | 0.32% | 0.48% | 2022-12-31 |
| CHECKPOINT CAPITAL L.P. | 466.81 tis | 0.40% | 6.02% | 12.23% | 2023-12-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 471.48 tis | 0.39% | 0.04% | 0.04% | 2019-06-30 |
| GW&K INVESTMENT MANAGEMENT, LLC | 472.36 tis | 0.39% | 0.17% | 0.26% | 2025-09-30 |
| ENSIGN PEAK ADVISORS, INC | 461.84 tis | 0.39% | 0.00% | 0.04% | 2019-12-31 |
| READYSTATE ASSET MANAGEMENT LP | 394.18 tis | 0.39% | 0.23% | 0.69% | 2023-12-31 |
| MILLENNIUM MANAGEMENT LLC | 458.68 tis | 0.38% | 0.00% | 0.01% | 2013-09-30 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 458.30 tis | 0.38% | 13.79% | 13.79% | 2025-09-30 |
| CATALIO CAPITAL MANAGEMENT, LP | 451.58 tis | 0.38% | 0.42% | 4.59% | 2024-12-31 |
| AMERICAN CENTURY COMPANIES INC | 432.73 tis | 0.36% | 0.00% | 0.01% | 2021-09-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 416.25 tis | 0.35% | 0.00% | 0.00% | 2018-06-30 |
| SIREN, L.L.C. | 402.32 tis | 0.34% | -0.55% | 0.84% | 2024-09-30 |
| E. OHMAN J:OR ASSET MANAGEMENT AB | 407.04 tis | 0.34% | -0.02% | 0.33% | 2025-03-31 |
| DAFNA CAPITAL MANAGEMENT LLC | 398.10 tis | 0.34% | -0.22% | 4.54% | 2021-09-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 383.18 tis | 0.33% | 0.00% | 0.01% | 2019-06-30 |
| RHUMBLINE ADVISERS | 378.68 tis | 0.32% | 0.00% | 0.02% | 2013-06-30 |
| FIRST TURN MANAGEMENT, LLC | 293.32 tis | 0.29% | -1.93% | 2.59% | 2023-12-31 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 266.70 tis | 0.26% | 0.66% | 1.55% | 2024-03-31 |
| RAFFERTY ASSET MANAGEMENT, LLC | 265.07 tis | 0.26% | 0.02% | 0.05% | 2019-03-31 |
| FINEPOINT CAPITAL LP | 256.45 tis | 0.25% | -0.34% | 3.94% | 2022-06-30 |
| PINNACLE ASSOCIATES LTD | 253.86 tis | 0.25% | -0.07% | 0.22% | 2017-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 253.49 tis | 0.25% | -0.01% | 0.02% | 2023-12-31 |
| THORNBURG INVESTMENT MANAGEMENT INC | 252.81 tis | 0.25% | 0.11% | 0.19% | 2022-09-30 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 197.52 tis | 0.19% | -0.29% | 1.03% | 2021-12-31 |
| SWISS NATIONAL BANK | 195.50 tis | 0.19% | 0.00% | 0.01% | 2017-06-30 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 179.74 tis | 0.18% | 0.00% | 0.01% | 2022-09-30 |
| CANDRIAM S.C.A. | 179.20 tis | 0.18% | -0.16% | 0.06% | 2020-09-30 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 173.78 tis | 0.17% | 0.00% | 0.01% | 2013-09-30 |
| LEGAL & GENERAL GROUP PLC | 168.90 tis | 0.17% | 0.00% | 0.00% | 2015-12-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Blum Robert I | director, officer: President & CEO | S-Sale | 7500 | 77.92 | 14.5 2026 | 400330 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 11333 | 39.13 | 5.5 2026 | 13070 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 11333 | 77.25 | 5.5 2026 | 58555 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 11333 | 39.13 | 5.5 2026 | 69888 |
| HENDERSON JOHN T | director | M-Exempt | 20000 | 7.61 | 5.5 2026 | 0 |
| HENDERSON JOHN T | director | S-Sale | 20000 | 75.97 | 5.5 2026 | 75237 |
| HENDERSON JOHN T | director | M-Exempt | 20000 | 7.61 | 5.5 2026 | 95237 |
| Lee Sung | officer: EVP, Chief Financial Officer | S-Sale | 23906 | 76.87 | 5.5 2026 | 63221 |
| WIERENGA WENDELL | director | M-Exempt | 4032 | 12.40 | 5.5 2026 | 0 |
| WIERENGA WENDELL | director | S-Sale | 4032 | 75.00 | 5.5 2026 | 32637 |
| WIERENGA WENDELL | director | M-Exempt | 4032 | 12.40 | 5.5 2026 | 36669 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3500 | 7.80 | 5.5 2026 | 51386 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 3500 | 77.37 | 5.5 2026 | 153902 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3500 | 7.80 | 5.5 2026 | 157402 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15857 | 37.63 | 4.5 2026 | 0 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 15857 | 65.00 | 4.5 2026 | 58555 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15857 | 37.63 | 4.5 2026 | 74412 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 30.4 2026 | 54000 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 15000 | 63.26 | 30.4 2026 | 58555 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 30.4 2026 | 73555 |
| Blum Robert I | director, officer: President & CEO | S-Sale | 7500 | 59.62 | 29.4 2026 | 407830 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3500 | 7.80 | 21.4 2026 | 54886 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 3500 | 65.69 | 21.4 2026 | 153902 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3500 | 7.80 | 21.4 2026 | 157402 |
| Blum Robert I | director, officer: President & CEO | S-Sale | 7500 | 65.38 | 15.4 2026 | 415330 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 7449 | 66.02 | 15.4 2026 | 58555 |
| Daly James M | director | A-Award | 191 | 65.37 | 15.4 2026 | 388 |
| Harrington Robert Arthur | director | A-Award | 191 | 65.37 | 15.4 2026 | 18930 |
| HENDERSON JOHN T | director | A-Award | 325 | 65.37 | 15.4 2026 | 75237 |
| Kaye Edward M. MD | director | A-Award | 191 | 65.37 | 15.4 2026 | 10365 |
| WIERENGA WENDELL | director | A-Award | 95 | 65.37 | 15.4 2026 | 32637 |
| Wysenski Nancy | director | A-Award | 95 | 65.37 | 15.4 2026 | 31066 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 1000 | 10.60 | 8.4 2026 | 0 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3500 | 7.80 | 8.4 2026 | 58386 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 1000 | 64.75 | 8.4 2026 | 153902 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 3500 | 65.21 | 8.4 2026 | 153902 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 1000 | 10.60 | 8.4 2026 | 154902 |
| Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3500 | 7.80 | 8.4 2026 | 157402 |
| Blum Robert I | director, officer: President & CEO | S-Sale | 7500 | 66.63 | 1.4 2026 | 422830 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 3639 | 65.00 | 31.3 2026 | 66004 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 1930 | 62.07 | 18.3 2026 | 78185 |
| Blum Robert I | director, officer: President & CEO | S-Sale | 23928 | 62.15 | 18.3 2026 | 430330 |
| Blum Robert I | director, officer: President & CEO | S-Sale | 12673 | 62.15 | 18.3 2026 | 454258 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 4397 | 62.15 | 18.3 2026 | 153902 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 7636 | 62.15 | 18.3 2026 | 158299 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 2916 | 62.15 | 18.3 2026 | 71573 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 5626 | 62.15 | 18.3 2026 | 74489 |
| Lee Sung | officer: EVP, Chief Financial Officer | S-Sale | 4935 | 62.15 | 18.3 2026 | 87127 |
| Malik Fady Ibraham | officer: EVP Research & Development | A-Award | 1665 | 60.06 | 17.3 2026 | 1665 |
| Malik Fady Ibraham | officer: EVP Research & Development | A-Award | 39527 | 60.06 | 17.3 2026 | 39527 |
| Malik Fady Ibraham | officer: EVP Research & Development | A-Award | 27306 | 0.00 | 17.3 2026 | 165935 |
| Lee Sung | officer: EVP, Chief Financial Officer | A-Award | 1665 | 60.06 | 17.3 2026 | 1665 |
| Lee Sung | officer: EVP, Chief Financial Officer | A-Award | 29480 | 60.06 | 17.3 2026 | 29480 |
| Lee Sung | officer: EVP, Chief Financial Officer | A-Award | 20646 | 0.00 | 17.3 2026 | 92062 |
| Hessekiel Jeffrey | officer: Chief Legal & Admin Officer | A-Award | 8325 | 60.06 | 17.3 2026 | 8325 |
| Hessekiel Jeffrey | officer: Chief Legal & Admin Officer | A-Award | 22820 | 60.06 | 17.3 2026 | 22820 |
| Hessekiel Jeffrey | officer: Chief Legal & Admin Officer | A-Award | 20646 | 0.00 | 17.3 2026 | 107943 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | A-Award | 1665 | 60.06 | 17.3 2026 | 1665 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | A-Award | 29480 | 60.06 | 17.3 2026 | 29480 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | A-Award | 20646 | 0.00 | 17.3 2026 | 68504 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | A-Award | 13320 | 0.00 | 17.3 2026 | 81824 |
| Blum Robert I | director, officer: President & CEO | A-Award | 1665 | 60.06 | 17.3 2026 | 1665 |
| Blum Robert I | director, officer: President & CEO | A-Award | 111864 | 60.06 | 17.3 2026 | 111864 |
| Blum Robert I | director, officer: President & CEO | A-Award | 75258 | 0.00 | 17.3 2026 | 466931 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 1709 | 61.03 | 16.3 2026 | 46149 |
| Blum Robert I | director, officer: President & CEO | S-Sale | 7931 | 60.72 | 10.3 2026 | 391673 |
| Malik Fady Ibraham | officer: EVP Research & Development | S-Sale | 2907 | 60.72 | 10.3 2026 | 138629 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 2582 | 60.72 | 10.3 2026 | 47858 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 11000 | 39.13 | 5.3 2026 | 24403 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 11000 | 61.88 | 5.3 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 15000 | 61.87 | 5.3 2026 | 61440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 5.3 2026 | 65440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 5.3 2026 | 69000 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 11000 | 39.13 | 5.3 2026 | 76440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 886 | 37.63 | 2.3 2026 | 0 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 886 | 61.62 | 2.3 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 886 | 37.63 | 2.3 2026 | 51326 |
| PARSHALL B LYNNE | director | S-Sale | 5000 | 61.21 | 2.3 2026 | 17933 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 15000 | 61.93 | 5.2 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 5.2 2026 | 65440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 5.2 2026 | 84000 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 886 | 37.63 | 2.2 2026 | 886 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 886 | 62.10 | 2.2 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 886 | 37.63 | 2.2 2026 | 51326 |
| Daly James M | director | A-Award | 197 | 63.44 | 20.1 2026 | 197 |
| Harrington Robert Arthur | director | A-Award | 197 | 63.44 | 16.1 2026 | 18739 |
| HENDERSON JOHN T | director | A-Award | 334 | 63.44 | 16.1 2026 | 74912 |
| Kaye Edward M. MD | director | A-Award | 197 | 63.44 | 16.1 2026 | 10174 |
| WIERENGA WENDELL | director | A-Award | 98 | 63.44 | 16.1 2026 | 32542 |
| Wysenski Nancy | director | A-Award | 98 | 63.44 | 16.1 2026 | 30971 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 15000 | 60.28 | 5.1 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 5.1 2026 | 65440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 15000 | 23.26 | 5.1 2026 | 99000 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 885 | 37.63 | 2.1 2026 | 1772 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 885 | 63.16 | 2.1 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 913 | 62.09 | 2.1 2026 | 50440 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 885 | 37.63 | 2.1 2026 | 51325 |
| Callos Andrew | officer: EVP, Chief Commercial Officer | S-Sale | 1809 | 62.44 | 30.12 2025 | 51353 |
| Blum Robert I | director, officer: President & CEO | F-InKind | 2935 | 62.72 | 29.12 2025 | 399604 |
| Blum Robert I | director, officer: President & CEO | A-Award | 5765 | 0.00 | 29.12 2025 | 402539 |
